"10.1371_journal.pone.0020565","plos one","2011-06-03T00:00:00Z","Uffe V Schneider; Imrich Géci; Nina Jøhnk; Nikolaj D Mikkelsen; Erik B Pedersen; Gorm Lisby","QuantiBact Inc, Hvidovre, Denmark; Nucleic Acid Center and Department of Chemistry, University of Southern Denmark, Odense, Denmark","Conceived and designed the experiments: UVS IG NJ NDM EBP GL. Performed the experiments: UVS IG NJ NDM. Analyzed the data: UVS IG NJ NDM EBP GL. Contributed reagents/materials/analysis tools: IG EBP. Wrote the paper: UVS GL.","EBP is co-inventor of the TINA molecule. QuantiBact Inc. has exclusive license to use TINA modified oligonucleotides for human diagnostics of infectious diseases. Quantibact Inc. seeks to make the use and design of TINA modified oligonucleotides known broadly within the scientific community. UVS, NJ, NDM and GL are employed by QuantiBact Inc. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","06","Uffe V Schneider","UVS",6,TRUE,6,4,6,2,TRUE,TRUE,FALSE,0,NA,FALSE
